Log in to save to my catalogue

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_228ee56caf814e7fbcca341ed093aaed

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Immunogenic cell death (ICD) converts dying cancer cells into a therapeutic vaccine and stimulates antitumor immune responses. Here we unravel the results of an unbiased screen identifying high-dose (10 µM) crizotinib as an ICD-inducing tyrosine kinase inhibitor that has exceptional antineoplastic activity when combined with non-ICD inducing chemot...

Alternative Titles

Full title

Crizotinib-induced immunogenic cell death in non-small cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_228ee56caf814e7fbcca341ed093aaed

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_228ee56caf814e7fbcca341ed093aaed

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-019-09415-3

How to access this item